AISAP’s CARDIO AI-powered Diagnostic Assessment Software Receives FDA Clearance
Imaging Technology
AUGUST 22, 2024
We know that structural heart disease and heart failure are the leading causes of hospitalization and morbidity in the U.S. It is a vendor-agnostic, scalable solution that seamlessly integrates into the clinical workflow, as well as existing EHR/EMR and PACS systems. Please visit www.aisap.ai for more information or to book a demo.
Let's personalize your content